Sign In

Kelly Mottet

Chief Operating Officer at MACH32

Professional Background

Kelly Mottet has an extensive and impressive career in the scientific and medical fields, notably stretching across various leadership and operational roles that emphasize her expertise in immunology, virology, and regulatory affairs. As the Chief Operating Officer at MACH32, Kelly is instrumental in managing operations and strategizing advancements in technology that can lead to impactful innovations in healthcare. Her hands-on experience and diverse background make Kelly a pivotal figure in developing strategies that aim to improve health outcomes through revolutionary medical solutions.

In her previous roles, particularly as the Vice President of Commercialization at MACH32, Kelly played a key role in bringing scientific advancements to market, ensuring that innovative products reach those who need them most. Her keen insight into commercialization strategies has proven to be a valuable asset, allowing her to bridge the gap between scientific research and practical application.

Prior to her time at MACH32, she served as the Director of Quality Assurance and Regulatory Affairs at Innovative Trauma Care Inc., where she ensured that the organization met stringent regulatory requirements and maintained high-quality standards in product development. Her expertise in quality assurance is a testament to her commitment to safety and efficacy in healthcare solutions. Kelly's journey also includes positions such as Project Manager in Research and Development, where she oversaw projects aimed at improving trauma care, highlighting her ability to manage complex initiatives in a fast-paced environment.

Education and Achievements

Kelly Mottet’s academic journey laid a strong foundation for her successful career in the biomedical field. She earned her B.Sc Honors in Immunology and Infection, followed by a Master’s in Science with a focus on Virology, both from the prestigious University of Alberta. This rigorous academic training equipped her with a deep understanding of viral diseases and immune responses, imperative knowledge for anyone working in health sciences or biotechnology.

In addition to her scientific credentials, Kelly pursued a Management Development Certificate in Business, also from the University of Alberta. This unique combination of scientific expertise paired with business acumen allows Kelly to tackle the dual challenges of scientific development and market readiness, effectively contributing to the growth of the organizations she is part of.

Notable Positions

Kelly has held various significant roles throughout her career that showcase her versatility and commitment to excellence. At Innovative Trauma Care Inc., she began as a Product Support Specialist and gradually advanced to the role of Director of Quality Assurance and Regulatory Affairs. In this transition, she honed her skills in not only managing product support and customer relations but also ensuring compliance with health regulations—a dual focus that has proven vital in her subsequent roles.

Moreover, Kelly's stint as the Director of Business Development and Marketing at IMBiotechnologies Ltd further highlights her strategic thinking and ability to drive organizational growth. By promoting innovative biotechnological solutions and developing marketing strategies, she has contributed to advancing the organization's missions in the marketplace.

Continuing her trajectory of excellence, Kelly also served as a Quality Assurance and Regulatory Specialist at the Li Ka Shing Applied Virology Institute, where she ensured the integrity of research projects focused on virology. As a Scientific Affairs Associate with Afexa Life Sciences, her contributions aided in the development of scientifically-backed products designed to enhance health and wellness.

Achievements

Throughout her career, Kelly Mottet has not only amassed extensive industry experience but has also achieved significant milestones that underscore her capabilities as a leader in the field. As COO at MACH32, she has been involved in projects aimed at harnessing cutting-edge technology to improve health outcomes, solidifying her reputation as an innovator in the healthcare sector.

Her ability to integrate her scientific knowledge with her operational expertise makes Kelly a formidable force, enabling her to oversee complex processes from inception through to implementation—a crucial aspect in any entrepreneurial or corporate venture in life sciences. Her leadership has helped organizations pivot, adapt, and thrive in the ever-evolving healthcare landscape, demonstrating her resilience and adaptability.

Both her educational background in Immunology and Virology, paired with her business-oriented management training, uniquely position her to contribute substantially to future advancements in the biotechnology sector. As Kelly continues to take on her role at MACH32 and potentially beyond, her dedication to enhancing healthcare through innovation remains a driving force in her professional narrative.

Related Questions

How did Kelly Mottet's education in Immunology and Virology shape her career in the medical technology sector?
In what ways does Kelly Mottet integrate her business acumen with her scientific background at MACH32?
What are some of the key strategies Kelly Mottet has implemented in her roles to ensure regulatory compliance and quality assurance?
How has Kelly Mottet contributed to the advancement of trauma care during her time at Innovative Trauma Care Inc.?
What challenges has Kelly Mottet faced while leading teams in the healthcare industry, and how has she overcome them?
Kelly Mottet
Add to my network

Location

Edmonton, Alberta, Canada